The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 4, Pages 841
Publisher
MDPI AG
Online
2020-04-01
DOI
10.3390/cells9040841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study
- (2020) Callum R. Smith et al. ACTA NEUROLOGICA SCANDINAVICA
- The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
- (2020) Marc van der Vlag et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Chitosan-DNA polyelectrolyte complex: Influence of chitosan characteristics and mechanism of complex formation
- (2019) Lourdes Mónica Bravo-Anaya et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- microRNA dysregulation in neurodegenerative diseases: A systematic review
- (2019) Camille A. Juźwik et al. PROGRESS IN NEUROBIOLOGY
- Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson’s disease model
- (2019) Li Gan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Parkinson disease
- (2019) R. Balestrino et al. EUROPEAN JOURNAL OF NEUROLOGY
- Role of MicroRNAs in Parkinson’s Disease
- (2019) Suh Yee Goh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA delivery through nanoparticles
- (2019) Sharon Wei Ling Lee et al. JOURNAL OF CONTROLLED RELEASE
- Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran
- (2019) Simoneide S. Titze-de-Almeida et al. Molecular Diagnosis & Therapy
- Lipid nanocarriers for microRNA delivery
- (2019) Marcel Scheideler et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy
- (2018) Daniel F. Costa et al. BIOMEDICAL MICRODEVICES
- miR-7 Replacement Therapy in Parkinson’s Disease
- (2018) Ricardo Titze-de-Almeida et al. CURRENT GENE THERAPY
- An overview of sleep and circadian dysfunction in Parkinson's disease
- (2018) Susanna Mantovani et al. JOURNAL OF SLEEP RESEARCH
- Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- (2018) Jose-Alberto Palma et al. MOVEMENT DISORDERS
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
- (2018) Emily M. Rocha et al. NEUROBIOLOGY OF DISEASE
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
- (2018) Mariza Bortolanza et al. JOURNAL OF NEURAL TRANSMISSION
- Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®
- (2018) Simoneide Titze de Almeida et al. MOLECULES
- Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
- (2018) Barry Boland et al. NATURE REVIEWS DRUG DISCOVERY
- Gene Co-Expression Network Analysis Implicates microRNA Processing in Parkinson’s Disease Pathogenesis
- (2018) Jason A. Chen Neurodegenerative Diseases
- Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
- (2018) Sara A. Ferreira et al. Frontiers in Cellular Neuroscience
- Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
- (2018) Stéphane Palfi et al. Human Gene Therapy Clinical Development
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
- (2018) Khosro Jamebozorgi et al. MOLECULAR NEUROBIOLOGY
- Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
- (2018) Fabio Blandini et al. MOVEMENT DISORDERS
- Downregulation of miR-7116-5p in microglia by MPP+ sensitizes TNF-α production to induce dopaminergic neuron damage
- (2017) Qian He et al. GLIA
- microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches
- (2017) Loredana Leggio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Parkinson's Disease Is Not Simply a Prion Disorder
- (2017) D. James Surmeier et al. JOURNAL OF NEUROSCIENCE
- Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo
- (2017) Kirsty J. McMillan et al. MOLECULAR THERAPY
- Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers
- (2017) Rahul Maheshwari et al. Nanomedicine
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNAs in Parkinson's disease and emerging therapeutic targets
- (2017) PhilipV Peplow et al. Neural Regeneration Research
- LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells
- (2017) Yuan Chen et al. NEUROTOXICOLOGY
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Chronic pain and pain processing in Parkinson's disease
- (2017) Pierre J. Blanchet et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy
- (2017) Steven J. Roeters et al. Scientific Reports
- Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
- (2017) Shuiqin Niu et al. Theranostics
- MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson’s Disease
- (2017) Yimeng Chen et al. Frontiers in Aging Neuroscience
- The Synucleinopathies: Twenty Years On
- (2017) Michel Goedert et al. Journal of Parkinsons Disease
- Oxidative stress and cellular pathologies in Parkinson’s disease
- (2017) Lesly Puspita et al. Molecular Brain
- Modulation of Alpha-synuclein Expression and Associated Effects by MicroRNA Let-7 in Transgenic C. elegans
- (2017) Shamsuzzama et al. Frontiers in Molecular Neuroscience
- Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson’s Disease
- (2017) Christin Helmschrodt et al. Molecular Therapy-Nucleic Acids
- Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy
- (2017) Cristina R. Reschke et al. Molecular Therapy-Nucleic Acids
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Chemical and structural modifications of RNAi therapeutics
- (2016) Sook Hee Ku et al. ADVANCED DRUG DELIVERY REVIEWS
- Effect of surface properties on liposomal siRNA delivery
- (2016) Yuqiong Xia et al. BIOMATERIALS
- Synergistic effect of phosphorothioate, 5′-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA
- (2016) Thazha P. Prakash et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Lentivirus-Mediated Overexpression of MicroRNA-210 Improves Long-Term Outcomes after Focal Cerebral Ischemia in Mice
- (2016) Li-Li Zeng et al. CNS Neuroscience & Therapeutics
- LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
- (2016) Jean-Marc Taymans et al. Current Neuropharmacology
- Lipid Nanoparticles to Deliver miRNA in Cancer
- (2016) Virginia Campani et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model
- (2016) G Liang et al. GENE THERAPY
- MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease
- (2016) C. Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Chronic, intermittent convection-enhanced delivery devices
- (2016) Owen Lewis et al. JOURNAL OF NEUROSCIENCE METHODS
- Brain Iron Metabolism Dysfunction in Parkinson’s Disease
- (2016) Hong Jiang et al. MOLECULAR NEUROBIOLOGY
- MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
- (2016) Yan Zhou et al. Molecular Neurodegeneration
- Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
- (2016) Shengpeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Evolving basic, pathological and clinical concepts in PD
- (2016) Lorraine V. Kalia et al. Nature Reviews Neurology
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Aptamers: A promising chemical antibody for cancer therapy
- (2016) Gang Zhou et al. Oncotarget
- Graded Proteasome Dysfunction in Caenorhabditis elegans Activates an Adaptive Response Involving the Conserved SKN-1 and ELT-2 Transcription Factors and the Autophagy-Lysosome Pathway
- (2016) Scott A. Keith et al. PLoS Genetics
- Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review
- (2016) Ming Ming Wen Frontiers in Molecular Neuroscience
- Mitochondrial dysfunction in Parkinson’s disease
- (2016) Qingsong Hu et al. Translational Neurodegeneration
- Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles
- (2015) Zvi R. Cohen et al. ACS Nano
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
- (2015) Huiyuan Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells
- (2015) Paresh Prajapati et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson’s disease mouse
- (2015) Zhao-Hui Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA let-7 Modulates the Immune Response to Mycobacterium tuberculosis Infection via Control of A20, an Inhibitor of the NF-κB Pathway
- (2015) Manish Kumar et al. Cell Host & Microbe
- α-Synuclein and Lewy pathology in Parkinsonʼs disease
- (2015) Lorraine V. Kalia et al. CURRENT OPINION IN NEUROLOGY
- MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression
- (2015) Savan Kabaria et al. FREE RADICAL BIOLOGY AND MEDICINE
- Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
- (2015) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death
- (2015) Amrita Datta Chaudhuri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics
- (2015) Cornelia Lorenzer et al. JOURNAL OF CONTROLLED RELEASE
- Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept
- (2015) Bo Halle et al. JOURNAL OF NEURO-ONCOLOGY
- Convection-enhanced delivery to the central nervous system
- (2015) Russell R. Lonser et al. JOURNAL OF NEUROSURGERY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Age- and manganese-dependent modulation of dopaminergic phenotypes in a C. elegans DJ-1 genetic model of Parkinson's disease
- (2015) Pan Chen et al. Metallomics
- Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents
- (2015) Jing Zhao et al. Nanomedicine
- Enduring high-efficiency in vivo transfection of neurons with non-viral magnetoparticles in the rat visual cortex for optogenetic applications
- (2015) Cristina Soto-Sánchez et al. Nanomedicine-Nanotechnology Biology and Medicine
- Structure of the toxic core of α-synuclein from invisible crystals
- (2015) Jose A. Rodriguez et al. NATURE
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
- (2015) V. Sanchez-Guajardo et al. NEUROSCIENCE
- Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
- (2015) Alessandro Bertucci et al. Small
- Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
- (2015) Ulf Dettmer et al. Nature Communications
- Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells
- (2015) B. Santos-Carballal et al. Scientific Reports
- Biomaterials for mRNA delivery
- (2015) Mohammad Ariful Islam et al. Biomaterials Science
- NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review
- (2015) Ruey-Horng Shih et al. Frontiers in Molecular Neuroscience
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
- (2015) Qinqin Wang et al. Translational Neurodegeneration
- Recent Advances in Nanoparticle-Mediated siRNA Delivery
- (2014) John-Michael Williford et al. Annual Review of Biomedical Engineering
- Human GABARAP can restore autophagosome biogenesis in aC. elegans lgg-1mutant
- (2014) Céline Jenzer et al. Autophagy
- Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer
- (2014) Xiongwei Deng et al. BIOMATERIALS
- Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus
- (2014) Eva M. Jimenez-Mateos et al. Brain Structure & Function
- The C. elegans LC3 Acts Downstream of GABARAP to Degrade Autophagosomes by Interacting with the HOPS Subunit VPS39
- (2014) Marion Manil-Ségalen et al. DEVELOPMENTAL CELL
- Current issues of RNAi therapeutics delivery and development
- (2014) D. Haussecker JOURNAL OF CONTROLLED RELEASE
- The screening of the 3′UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson’s disease
- (2014) Lucía F Cardo et al. JOURNAL OF HUMAN GENETICS
- LRRK2 pathobiology in Parkinson's disease
- (2014) Ian Martin et al. JOURNAL OF NEUROCHEMISTRY
- MicroRNA-7 Protects against 1-Methyl-4-Phenylpyridinium-Induced Cell Death by Targeting RelA
- (2014) D. C. Choi et al. JOURNAL OF NEUROSCIENCE
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice
- (2014) J. Mark Cooper et al. MOVEMENT DISORDERS
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling
- (2014) Woori Kim et al. NEUROBIOLOGY OF AGING
- Downregulation of miR-124 in MPTP-treated mouse model of Parkinson’s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins
- (2014) N. Kanagaraj et al. NEUROSCIENCE
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
- (2014) Trinna L. Cuellar et al. NUCLEIC ACIDS RESEARCH
- Establishment of Lipofection for Studying miRNA Function in Human Adipocytes
- (2014) Eveliina Enlund et al. PLoS One
- Combined Magnetic Nanoparticle-based MicroRNA and Hyperthermia Therapy to Enhance Apoptosis in Brain Cancer Cells
- (2014) Perry T. Yin et al. Small
- miR-16-1 Promotes the Aberrantα-Synuclein Accumulation in Parkinson Disease via Targeting Heat Shock Protein 70
- (2014) Zhelin Zhang et al. TheScientificWorldJOURNAL
- miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway
- (2014) Apostolia Fragkouli et al. Frontiers in Cellular Neuroscience
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Characterization of Polyethylene Glycol-Polyethyleneimine as a Vector for Alpha-Synuclein siRNA Delivery to PC12 Cells for Parkinson's Disease
- (2013) Yun-Yun Liu et al. CNS Neuroscience & Therapeutics
- Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells
- (2013) C. Mattu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model
- (2013) Marcio Lazzarini et al. GLIA
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice
- (2013) Lee J. Martin et al. NEUROBIOLOGY OF AGING
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- α-Synucleinopathy phenotypes
- (2013) Heather McCann et al. PARKINSONISM & RELATED DISORDERS
- TFEB-mediated autophagy rescues midbrain dopamine neurons from -synuclein toxicity
- (2013) M. Decressac et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease
- (2013) L Alvarez-Erviti et al. Cell Death & Disease
- Programmed Cell Death in Parkinson's Disease
- (2013) K. Venderova et al. Cold Spring Harbor Perspectives in Medicine
- Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2
- (2013) Jiajie Diao et al. eLife
- The prion hypothesis in Parkinson's disease: Braak to the future
- (2013) Naomi P Visanji et al. Acta Neuropathologica Communications
- N-hexanoyl, N-octanoyl and N-decanoyl chitosans: Binding affinity, cell uptake, and transfection
- (2012) Buddhadev Layek et al. CARBOHYDRATE POLYMERS
- Attacking the genome: emerging siRNA nanocarriers from concept to clinic
- (2012) Christopher Alabi et al. CURRENT OPINION IN PHARMACOLOGY
- MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS
- (2012) Eugene D. Ponomarev et al. GLIA
- MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein
- (2012) Hyun Jin Cho et al. HUMAN MOLECULAR GENETICS
- Discovering the first microRNA-targeted drug
- (2012) Morten Lindow et al. JOURNAL OF CELL BIOLOGY
- Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
- (2012) Diana Guzman-Villanueva et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
- (2012) Eva M Jimenez-Mateos et al. NATURE MEDICINE
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- MicroRNAs in Parkinson's disease
- (2012) M. Maral Mouradian NEUROBIOLOGY OF DISEASE
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- The Business of RNAi Therapeutics in 2012
- (2012) Dirk Haussecker Molecular Therapy-Nucleic Acids
- Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
- (2011) Yi-Ping Yang et al. BIOMATERIALS
- MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
- (2011) A. F. Ibrahim et al. CANCER RESEARCH
- MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function
- (2011) Elena Miñones-Moyano et al. HUMAN MOLECULAR GENETICS
- Effect of Acyl Chain Length and Unsaturation on Physicochemical Properties and Transfection Efficiency of N-Acyl-Substituted Low-Molecular-Weight Chitosan
- (2011) Rhishikesh Mandke et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
- (2011) Kurt A. Jellinger MOVEMENT DISORDERS
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
- (2011) Madalena Martins et al. PLoS One
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
- (2010) Thomas G. Beach et al. ACTA NEUROPATHOLOGICA
- DC-Chol/DOPE cationic liposomes: A comparative study of the influence factors on plasmid pDNA and siRNA gene delivery
- (2010) Yang Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
- (2010) Epaminondas Doxakis JOURNAL OF BIOLOGICAL CHEMISTRY
- Transfection Techniques for Neuronal Cells
- (2010) D. Karra et al. JOURNAL OF NEUROSCIENCE
- Inflammation and Parkinson's disease pathogenesis
- (2010) Serge Przedborski MOVEMENT DISORDERS
- Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
- (2010) Stephan Gehrke et al. NATURE
- The Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery
- (2010) Xudong Yuan et al. PHARMACEUTICAL RESEARCH
- Hsp70 molecular chaperones and Parkinson's disease
- (2009) Stephan N. Witt BIOPOLYMERS
- Delivery of small-interfering RNA (siRNA) to the brain
- (2009) Saroj P Mathupala EXPERT OPINION ON THERAPEUTIC PATENTS
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
- (2009) Truyen Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease
- (2009) Sotiria Sotiriou et al. NEUROSCIENCE LETTERS
- Synthesis and characterization of 2′-modified-4′-thioRNA: a comprehensive comparison of nuclease stability
- (2009) Mayumi Takahashi et al. NUCLEIC ACIDS RESEARCH
- Repression of -synuclein expression and toxicity by microRNA-7
- (2009) E. Junn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of Parkinson's disease: emerging role of molecular chaperones
- (2009) Rina Bandopadhyay et al. TRENDS IN MOLECULAR MEDICINE
- Recombinant adeno-associated virus-mediated microRNA delivery into the postnatal mouse brain reveals a role for miR-134 in dendritogenesis in vivo
- (2009) Mette Christensen Frontiers in Neural Circuits
- The NF- B Family of Transcription Factors and Its Regulation
- (2009) A. Oeckinghaus et al. Cold Spring Harbor Perspectives in Biology
- Peripheral cytokines profile in Parkinson’s disease
- (2008) M. Reale et al. BRAIN BEHAVIOR AND IMMUNITY
- LNA-mediated microRNA silencing in non-human primates
- (2008) Joacim Elmén et al. NATURE
- Direct CNS Delivery of siRNA Mediates Robust Silencing in Oligodendrocytes
- (2008) William Querbes et al. OLIGONUCLEOTIDES
- Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
- (2008) Hui-Ming Gao et al. TRENDS IN IMMUNOLOGY
- Glial reactions in Parkinson's disease
- (2007) Patrick L. McGeer et al. MOVEMENT DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started